CompuGroup Medical Strengthens its Market Position in the Netherlands

CompuGroup MedicalCompuGroup Medical concluded an agreement to acquire 100% of the shares in Microbais Werkmaatschappij B.V.. Microbais is one of the market leaders in ambulatory and pharmacy information systems in the Netherlands. The 2011 turnover is expected to amount to 11.2 million Euro with about 70% recurring revenue and EBITDA is expected to be 2.5 million Euro.

Microbais employs around 90 employees and is headquartered in Amsterdam. Around 475 pharmacies as well as 150 doctors' practices count among the company's customers. This is equivalent to a market share of about 25% within pharmacies and 4% within office-based physicians.

With this acquisition CompuGroup Medical increases its market shares in the Dutch pharmacy and doctor software markets to around 45% and 15% respectively. Customers will be provided with access to the international product platform of CompuGroup Medical and benefit from SAM solutions (intelligent software assisted medicine) that are worldwide leading in terms of innovation and security.

In this transaction CompuGroup Medical also acquires a 51% majority holding in MediPharma Online, a start-up enterprise in the field of networking between patients and pharmacies.

Frank Gotthardt, CEO of CompuGroup Medical AG, underlined the relevance of this acquisition: "After the successful acquisition of Ascon Euroned, today CGM Netherlands, the purchase of Microbais is a crucial step towards extending the market position in the Dutch pharmacy software sector. At the same time we strengthen our coverage in the field of ambulatory information systems. The highly positive feedback from shareholders and employees of Microbais regarding this transaction encourages us in using this excellent start into the year 2012 with full power in the best interest of our customers."

The purchase price amounts to approximately 15,0 million Euro and will be financed from existing cash and credit facilities.

Related news articles:

About CompuGroup Medical AG
CompuGroup Medical is one of the leading eHealth companies in the world. Its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of over 385,000 doctors, dentists, hospitals, pharmacies and networks as well as other service providers. With locations in 19 countries and customers in 33 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 3,600 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...